FDA Import Refusal 799-1082414-6/40003/1 — Merck Limited

Merck Limited — FEI 3012003989

The FDA refused shipment 799-1082414-6/40003/1 from Merck Limited (India) on Jan 12, 2026. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
Jan 12, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61PDA68 SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
Charges
118,75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.